JNJ
Johnson & Johnson
NYSE
Healthcare
$263.85
-3.80
(-1.42%)
Updated: 10/23/2026, 8:55:01 PM
Open
$265.82
High
$267.22
Low
$262.43
Prev Close
$267.61
Volume
3.76M
Price History
Why Is JNJ ▼ Down Today?
-1.42%
Full AI analysis generates after market close. Showing live price data.
Oct 23
▼
-1.4%
Johnson & Johnson Dips Slightly, Tracking Broader Healthcare Sector
Oct 22
▲
+3.6%
Johnson & Johnson Surges on Positive Clinical Data and Raised Guidance
Oct 21
▼
-0.6%
Johnson & Johnson Posts Modest Dip, Outperforms Sector
Oct 20
▲
+2.0%
Johnson & Johnson Rises Amidst Broader Sector Gains
Oct 19
▼
-1.1%
JNJ falls over 1%, underperforming sector's general decline
Oct 16
▲
+1.0%
JNJ Rises Over 1% Following Recent Q3 2026 Earnings Report
Oct 15
▼
-0.2%
J&J Dips Slightly Amid Post-Earnings MedTech Concerns
Oct 14
▲
+2.1%
JNJ Rebounds After Q3 Earnings, Raised Guidance Fuels Gains
Oct 13
▼
-5.5%
J&J Shares Drop Over 5% on Mixed Q3 Earnings Report
Oct 12
▲
+0.9%
JNJ Rises Ahead of Q3 Earnings Report, Outperforming Sector
Oct 9
▲
+1.8%
Johnson & Johnson rises, buoyed by positive oncology sector sentiment
Oct 8
▼
-0.8%
JNJ Outperforms Sector Amidst Modest Daily Decline
Oct 7
▲
+1.3%
Johnson & Johnson (JNJ) Posts Modest Gains Amid Positive Sector Trend
Oct 6
▲
+0.7%
Johnson & Johnson Edges Higher, Outperforming Sector
Oct 5
▼
-1.2%
JNJ Shares Decline Amid Broader Healthcare Sector Weakness
Oct 2
▼
-1.0%
Johnson & Johnson Dips, Underperforms Sector
Oct 1
▼
-2.1%
Johnson & Johnson Shares Decline, Underperforming Sector
Sep 30
▼
-1.0%
JNJ Outperforms Sector Amidst Modest Decline
Sep 29
▼
-1.6%
JNJ Shares Decline, Underperforming Broader Healthcare Sector
Sep 28
▲
+0.3%
Johnson & Johnson Posts Modest Gain, Trails Sector Average
Sep 25
—
+0.0%
JNJ posts marginal gain on low volume, underperforms sector
Sep 24
▲
+0.9%
JNJ posts modest gain, slightly outperforming healthcare sector
Sep 23
▼
-0.4%
JNJ posts modest decline, outperforms sector average
Sep 22
▼
-0.1%
Johnson & Johnson sees slight dip, underperforming sector
Sep 21
▼
-0.2%
JNJ sees slight dip as sector outperforms
Sep 18
—
-0.1%
Johnson & Johnson Dips Slightly, Underperforming Sector Average
Sep 17
▲
+1.1%
Johnson & Johnson Rises, Outperforming Sector Amid Positive Biotech Outlook
Sep 16
—
+0.0%
JNJ Edges Up Amidst Positive Pharmaceutical Market Outlook
Sep 15
▲
+0.3%
Johnson & Johnson Posts Modest Gain, Outperforms Declining Healthcare Sector
Sep 14
▲
+0.3%
JNJ posts modest gain, underperforming sector on lower volume
Financial Highlights
Income Statement
Revenue
$92.15B
Gross Profit
$62.73B
68.1% margin
Operating Income
$31.50B
34.2% margin
Net Income
$25.12B
27.3% margin
EPS (Diluted)
$10.36
Balance Sheet
Total Assets
$192.82B
Total Liabilities
$113.54B
Stockholders' Equity
$79.28B
Cash Flow
Operating Cash Flow
$24.20B
Investing Activities
-$20.42B
Net Cash Flow
-$1.75B
Highly Regarded Analysis for JNJ
Get a deep-dive analysis including bull/bear cases, technical outlook, price targets, and key catalysts — powered by Highly Regarded's proprietary analysis engine.
Usually takes 10-20 seconds
Analyzing JNJ...
Searching financial data and generating insights
Analysis couldn't be generated
Go Deeper on JNJ
Key Stats
P/E Ratio
25.5x
EPS (Diluted)
$10.36
Gross Margin
68.1%
Operating Margin
34.2%
Net Margin
27.3%
Revenue (Qtr)
$92.15B
Shares Outstanding
2.41B
Next Earnings
Date
Jan 20, 2027
Time
Before Open
Quarter
Q4 2026
EPS Estimate
$2.93
JNJ News
No recent news for JNJ.
